ESTRO 2025 - Abstract Book

S1122

Clinical – Head & neck

ESTRO 2025

Conclusion: PT provided an excellent LRFS and PFS with a safety toxicity profile. In the field of high precision therapy, PT represents a safe strategy in managing locally advanced SNCs. International PT register and randomized clinical trials are needed to optimize pts selection.

Keywords: sinonasal cancer, proton therapy, outcomes